PubMed Identification:

Starting with   __   _1   _2   _3   _4   _5   _6   _7   _8   _9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34

PMID
Data
Article Title
Citation
Organization
Data Download
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 MBDB
Proc Natl Acad Sci U S A 118: (2021)
Baylor College of Medicine
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir.BDB
ACS Pharmacol Transl Sci 4: 1408-1421 (2021)
The University of Arizona
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency.BDB
ACS Med Chem Lett 12: 1325-1332 (2021)
Yale University
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLBDB
J Med Chem 64: (2021)
Cleveland Clinic
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors.BDB
Bioorg Med Chem Lett 48: 128263 (2021)
A*STAR
Peptidomimetic ?-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and BDB
J Med Chem (2021)
University of Alberta
Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.BDB
J Med Chem 64: 10047-10058 (2021)
Wichita State University

BDB Curated by BindingDB
EBI Curated by ChEMBL